<?xml version="1.0" encoding="UTF-8"?>
<p>All existing antimicrobial agents interfere with essential bacterial growth and metabolic processes or the integrity of the cell. Unfortunately, targeting such vital functions introduces selection pressure for resistant strains and promotes evolution of resistance. The evidence for this is apparent with the rise of antibiotic resistance in hospitals and communities, most notably with organisms such as methicillin-resistant 
 <italic>Staphylococcus aureus</italic>, vancomycin-resistant 
 <italic>Enterococcus</italic>, carbapenem-resistant Enterobacteriaceae (including 
 <italic>Escherichia coli</italic>), multidrug-resistant 
 <italic>Acinetobacter</italic>, drug-resistant 
 <italic>Campylobacter</italic>, multidrug-resistant 
 <italic>Pseudomonas aeruginosa</italic>, drug-resistant 
 <italic>Streptococcus pneumoniae</italic>, drug-resistant 
 <italic>Neisseria gonorrhoeae</italic>, and multidrug-resistant and extensive drug-resistant 
 <italic>Mycobacterium tuberculosis</italic> [
 <xref rid="B5" ref-type="bibr">5</xref>].
</p>
